Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Medscape Oncology at ASCO 2025: Driving Innovation, Education & Better Patient Outcomes

May 22, 2025 |  

- PMLiVE

Medscape Oncology is making a powerful impact at ASCO 2025, bringing seven high-impact symposia, new research insights, and the return of the Medscape Fellows Program—all aimed at educating the next generation of oncology professionals advancing clinical practice and improving patient outcomes 

Fellows Program Returns—Stronger Than Ever

The Medscape ASCO Fellows Program is back for its second year, offering hematology/oncology fellows a chance to:

  • Participate in exclusive focus groups with Medscape Oncology
  • Attend and network with expert faculty at our symposia
  • Share their ASCO experiences live from the Medscape Studio

“We’re thrilled to bring the Fellows Program back to ASCO. This initiative not only supports the next generation of oncologists but also helps them engage in meaningful learning and connect directly with leaders in the field,” said Jelena Spyropoulos 

If you’re passionate about advancing cancer care, Medscape Oncology at ASCO 2025 is the place to be. Join us as we deliver education that drives change—because informed clinicians mean better outcomes for patients.

7 Symposia! Where Science Meets Practice:

This year’s Medscape Oncology symposia go beyond the latest data—they’re designed to translate emerging science into actionable clinical strategies for real-world practice. Here’s a look at what’s in store:

  • Latest Advances in Tumor-Agnostic Strategies for NTRK Fusion-Positive Cancer: Translating Science into Clinical Practice– Explore how tumor-agnostic therapies are reshaping precision oncology through earlier detection and personalized treatment.

 

  • Myelofibrosis: Clinical Updates and Best Practices for the Community Hematology/Oncology Clinic: Updates for the Community Hematology/Oncology Clinic- Stay ahead with the latest in therapies, risk tools, and symptom management tailored for community practice.

 

  • The Gynecologic Oncology Clinic: Real-time Case Review of Patients With Endometrial or Ovarian Cancer: Walk through real patient cases with expert faculty to enhance your approach to diagnosing and treating gynecologic cancers.


  • Clinical Integration of Therapeutic Innovations in Glioma: Pathways to Improved Patient Outcomes: Explore how cutting-edge treatments are transforming glioma care—and how to apply them in practice.


  • Bispecific Antibodies in R/R FL and R/R DLBCL: Aligning on Clinical Best Practices Learn to leverage bispecific antibodies in relapsed/refractory lymphomas with emerging best practices.


  • Changing Your Practice in Squamous Cell Carcinoma of the Anal Canal: Uncover how new therapies and biomarkers are redefining standards in this underserved cancer type.


  • A Day in the Community Oncology Clinic: Exploring Molecularly Altered NSCLC: Explore real-world cases that showcase the impact of biomarker-driven treatments in NSCLC.

Register for the symposia here

Each session is built for clinical relevance, interactivity, and practical insights, so learners leave with tools they can apply immediately. All symposia will also be available for CME/CE credit at Medscape.org.

Elevating Education with Data-Driven Outcomes

Medscape Oncology will also debut three new e-publications on the ASCO website, showcasing the measurable impact of our programs on findings from a comprehensive patient survey on nonmelanoma skin cancer and breast cancer education. These publications demonstrate how education can drive real-world improvements in care.

  1. Patient perspectives on nonmelanoma skin cancer care: insights into treatment, barriers, and healthcare gaps –https://meetings.asco.org/abstracts-presentations/248219
  2. Enhancing care of patients with HR+/HER2- early breast cancer at high risk of recurrence through an expansive curriculum: real-world outcomes (RWO) a 6-month analysis https://meetings.asco.org/abstracts-presentations/244642
  3. Is increase in CME consumption associated with practice change in the real world? An empirical study among oncologists treating breast cancer https://meetings.asco.org/abstracts-presentations/248318

Want to learn more?

Contact Jelena Spyropoulos (jspyropoulos@medsacpe.net) for details on Medscape Oncology and our full ASCO 2025 programming.

This content was provided by Medscape Education

Company Details

Medscape Logo

Medscape Education

Email
Website

 Latest Content from  Medscape Education 

The Heart and Mouth Connection Every Woman Needs to Know

For decades, modern medicine has treated the mouth and the body as separate entities. But for Dr. Nieca Goldberg, a renowned cardiologist, and Dr. Maria Ryan, Chief Clinical Officer at...

Uncovering Inequities in Alzheimer’s Disease Screening and Care

  On December 5, MAPS hosted an educational webinar exploring recent research in Alzheimer’s disease (AD) screening, testing, and treatment. Experts from Komodo Health and Medscape shared findings from their...

Where Are We Today With Artificial Intelligence (AI) in Rare Disease Diagnosis and Care?

Discover how AI-powered tools are transforming rare disease diagnosis, patient care, and clinical decision-making.

Does Rare Disease Education Work?

For a child with a rare disease, a doctor’s continuing education can end a years-long diagnostic odyssey and unlock access to vital care.

From Genetic Puzzles to Precision Therapeutics

How was a new rare disease discovered through Singapore’s Undiagnosed Disease Program? And how will technology allow us to change how we discover rare diseases in the future? Read more...

Medscape and the GNNRD: Empowering Nurses With a Rare Disease Education Series

Nurses play a vital and multifaceted role in rare disease care, providing consistent patient support, education, and care coordination, and ongoing education is essential to empower them to meet the...

What Is the RDI-Lancet Commission for Rare Disease and What Will It Achieve?

Christy Rohani-Montez, Medscape’s Rare Disease Education Lead recently spoke with Dr Lucy McKay, CEO, and Megan Pullein, Strategic Operations Officer from the UK-based charity Medics for Rare Disease (MfRD). We...

“CGM Sweet Talk With the Sugar Queens” Takes Silver at the 2025 Digital Health Awards

Medscape Education’s dynamic educational series, CGM Sweet Talk With the Sugar Queens, has earned a Silver Award in the Video Series (Digital Health Media / Publications) category at the 2025...

Medscape at ASH 2025: Landmark Value Through the Medscape AI Debut and Five Educational Symposia

For decades, Medscape has been the brand physicians trust. Now, Medscape is forging a new path into the future at ASH 2025 with the launch of Medscape AI — the...

Women Leaders Rewriting the Protocols of Rare Disease Care

The true measure of a medical leader is the courage to act when existing systems fail the patient. This is the professional and personal ethos of clinical immunologist Dr. Hilary...